1989
DOI: 10.1016/0002-9149(89)90975-2
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous nicardipine in severe systemic hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1991
1991
2006
2006

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…Intravenous nicardipine has been shown to decrease arterial BP acutely in non-pregnant subjects, when given either by bolus [3] or by continuous infusion [4,5]. Intravenous nicardipine has been shown to decrease arterial BP acutely in non-pregnant subjects, when given either by bolus [3] or by continuous infusion [4,5].…”
Section: Discussionmentioning
confidence: 99%
“…Intravenous nicardipine has been shown to decrease arterial BP acutely in non-pregnant subjects, when given either by bolus [3] or by continuous infusion [4,5]. Intravenous nicardipine has been shown to decrease arterial BP acutely in non-pregnant subjects, when given either by bolus [3] or by continuous infusion [4,5].…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have investigated the role of nicardipine when administered to patients with severe hypertension (85,86). In two multicenter, prospective randomized trials comparing nicardipine with nitroprusside in patients with severe postoperative hypertension, Halpern et al and Neuteal et al reported that nicardipine is as effective as nitroprusside (87,88).…”
Section: Pharmacologic Agents Available For Treatment Of Hypertensivementioning
confidence: 99%
“…Nicardipinc and isradipine. Some of the newer calciumchannel blockers have been studied for the treatment of hypertensive crises (89, 91, [103][104][105]. Sublingual nicardipine, a second-generation calcium-channel b l d e r similar to nifedipine, was compared with nifedipine in patients with hypertensive urgencies (91).…”
Section: Calcium-channel Blockersmentioning
confidence: 99%
“…Nicardipine and isradipine are not yet approved in the U.S.A. for the treatment of hypertensive crises. Based on the results from 66 patients, intravenous nicardipine appears to be a useful and safe agent for the management of this condition (105). Further study will be needed to determine the utility of orally and sublingually administered nicardipine and isradipine.…”
Section: Calcium-channel Blockersmentioning
confidence: 99%